K63.8219
Small intestinal bacterial overgrowth, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Small intestinal bacterial overgrowth (SIBO) is a condition characterized by an abnormal increase in the number or types of bacteria in the small intestine. Normally, the small intestine has fewer bacteria compared to other parts of the digestive system, but in SIBO, these bacteria multiply excessively, disrupting normal digestion and nutrient absorption. This condition can lead to various gastrointestinal symptoms and may contribute to nutritional deficiencies if left untreated. SIBO is often diagnosed using specialized tests, and its management typically involves dietary modifications and antibiotics.
Causes & Symptoms
Clinical Causes: Impaired motility of the small intestine, which can lead to bacteria stagnation and overgrowth Structural abnormalities such as diverticula or strictures in the small intestine Reduced gastric acid production, allowing bacteria to survive and proliferate in the small intestine Certain medical conditions like diabetes or scleroderma that affect gut motility Use of medications that affect gut bacteria, including antibiotics and proton pump inhibitors Previous gastrointestinal surgeries that alter the normal flow of digestive contents
Key Symptoms: Bloating and a sense of abdominal fullness Chronic diarrhea or loose stools Unexplained weight loss Malnutrition and nutrient deficiencies Abdominal cramps or discomfort Nausea and sometimes vomiting Burping and gas
Diagnostic & Treatment
Diagnosis Path: Diagnosing SIBO involves a combination of clinical evaluation and specialized testing. The most common tests include breath tests, where the patient ingests a sugar solution such as lactulose or glucose, and the levels of hydrogen and methane gases in the breath are measured over time. Elevated levels suggest overgrowth of bacteria in the small intestine. Additional assessments may involve endoscopic procedures or imaging studies to identify underlying anatomical issues. Healthcare providers will also review the patient’s medical history and symptoms to aid diagnosis.
Treatment Protocols: Antibiotic therapy: A course of broad-spectrum antibiotics such as rifaximin is often used to reduce bacterial population in the small intestine Dietary modifications: Implementing low FODMAP diets or other digestion-friendly diets can help minimize symptoms Addressing underlying conditions: Managing issues like motility disorders or structural abnormalities when possible Prokinetics: Medications that stimulate normal gut motility may be prescribed to prevent recurrence Nutritional support: Supplementing deficiencies caused by malabsorption, including vitamins and minerals Monitoring and follow-up: Periodic testing and assessments to confirm eradication of bacterial overgrowth and prevent relapse
Clinical Advice & FAQs
Billing Guidance
Is K63.8219 a billable ICD-10 code?
Yes, K63.8219 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K63.8219?
Clinical documentation must specify the nature of Small intestinal bacterial overgrowth, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference